The most useful information in a CIM is rarely in any single section. It's in the cracks between sections.

Several diligence engagements I've worked on came down to a single observation that wasn't in any one section of the CIM. The CIM was thorough. Each section was internally polished. The risk that mattered showed up in the inconsistency between sections, not in the content of any single one. CIMs are written to tell a story. Diligence is the work of finding the story the CIM didn't tell.

Four sections. Three cracks. The risk lives in the arrows.

Each section of a CIM is internally consistent. The cracks live between them. Below is a stylized view of where the page-spanning arrows usually point.

Growth Customers Team Roadmap concentration mismatch capability gap thesis vs. roadmap

The story is on the page. The risk is between the pages.

CIMs hide the answer the way you'd expect.

CIMs aren't dishonest. They're optimized. Each section is written to communicate that section's story, and the editing process smooths away anything that would surface tension with a different section. Four structural features of how CIMs get produced create the blind spots diligence has to find.

Polish per section. Each section is rewritten until it's internally consistent. The rough edges that would surface tension with other sections get smoothed away in the editing process, not because anyone is hiding anything, but because the editor's job is making each section read clean.

Selected emphasis. Each section emphasizes the metrics that flatter that section's story. The metrics that would complicate it are technically present but get less prominence. They live in a footnote, an appendix, or a column of a table that no one reads top to bottom.

Definitional choices. Each section uses the definitions that work best for that section. Customer counts, ARR, churn, growth: each can be defined in defensible ways that produce different numbers. The definitions don't always reconcile across the document.

Structural omission. Some risks live between functions and don't have a natural section in the CIM template. They get distributed across multiple sections in fragments, none of which are sufficient on their own. Diligence has to assemble them.

The CIM tells the truth. It just doesn't tell all of it in one place.

The cracks I look for first.

These are the inconsistencies I've learned to read for, in roughly the order I check them. None of them require information that isn't in the CIM. All of them require reading sections against each other rather than in sequence.

Crack 01

Growth versus customer concentration.

The growth chart shows expansion. The customer concentration table shows revenue concentrated in a small number of accounts. Each is internally fine. Read together, the picture changes.

The risk The growth might be coming from a single account that's about to recontract.
Crack 02

Team narrative versus org chart.

The team section celebrates specific people by name. The org chart in the appendix shows those people reporting to someone who's leaving, or in roles that don't have the authority the narrative implies.

The risk The strong operators highlighted in the narrative may not have the authority to deliver the value creation plan.
Crack 03

Churn definition versus revenue trajectory.

The churn cohort uses a definition that excludes the segments where the actual churn lives. The revenue trajectory looks better than the underlying customer health.

The risk The reported retention number is structurally optimistic for the part of the book the thesis depends on.
Crack 04

TAM versus actual customer shape.

The TAM analysis assumes a customer profile. The actual customer logos imply a different market. The growth case depends on a market the company isn't currently selling into.

The risk The growth thesis requires a go-to-market motion the team has not yet built or proven.
Crack 05

Cost structure versus headcount plan.

The unit economics work at the current scale. The headcount plan to support the growth case implies a cost structure that breaks the unit economics. This is rarely surfaced explicitly.

The risk The plan that gets the company to the growth target is the plan that erodes the margin profile the thesis depends on.
Crack 06

Product roadmap versus investment thesis.

The product section describes what the team is building. The investment thesis depends on the team building something different. The two narratives never get cross-referenced.

The risk The team is building the wrong roadmap to deliver the deal thesis, and nobody surfaced it pre-close.

Three customers and a renewal cliff.

Setup

A CIM crosses my desk for a growth-stage SaaS company. The pitch is an AI-forward growth story. Strong growth chart. Strong customer logos. Strong team narrative. The financial diligence comes back clean. The deal looks defensible.

Discovery

I was reading the customer concentration appendix when I flagged the top three customers were 71 percent of revenue. The CIM didn't hide it. It was right there in the appendix. But the growth narrative on page 14 didn't acknowledge it. And two of those three customers had renewals coming up in nine months. The thesis assumed 35 percent annual growth. The customer concentration math said the thesis depended on retaining those two contracts and growing the rest of the book by 80 percent.

Outcome

That wasn't the deal that was being sold. The CIM positioned this as an AI-forward growth story. The actual story was three customers and a renewal cliff.

Composite scenario based on common patterns in growth-stage SaaS CIMs.

Six questions for the deal team.

Yes or no, asked of the deal team or the analyst who built the diligence file. Six cross-section reads that are easy to skip and expensive to skip. The questions are blunt by design. Hedging defeats the point. If the honest answer is yes-but, it's a no.

  1. Has anyone cross-referenced the growth chart against the customer concentration table?
  2. Does the team narrative align with the org chart in the appendix, or are key people in roles that don't have the authority the narrative implies?
  3. Does the churn cohort definition include the segments where churn would be most likely?
  4. Does the TAM analysis align with the actual customer logos, or does it imply a market the company isn't currently in?
  5. Does the headcount plan support the growth case at the implied unit economics, or does it break them?
  6. Does the product roadmap reflect the investment thesis, or does it reflect the team's existing backlog?
Five or six yeses: the CIM and the underlying business are reconciled. Three or four: there are cracks worth investigating before the LOI. Fewer than three: the CIM is telling a different story than the business is.

Output that changes the term sheet, not just the diligence file.

Systematic crack-finding isn't a list of nitpicks. It's a structured cross-reference that produces three artifacts the deal team can act on directly. Each one has to land in the IC memo, not in a separate appendix.

A documented cross-reference of the major narrative claims against the underlying data.

Each major claim in the CIM gets paired with the underlying table, footnote, or appendix entry. Where the claim and the data agree, the cross-reference confirms it. Where they don't, the gap gets named and dated.

An explicit list of the cracks that warrant follow-up before LOI.

Each crack is described in plain language, ranked by deal impact, and tagged with the question to send back to the seller. The list goes to the deal team in time for the LOI conversation, not after.

A risk-priced view of which cracks change the deal terms and which don't.

Some cracks are fatal to the thesis. Some change the price. Some are worth knowing but priced into the existing model. Each crack gets a tag, an estimated dollar impact, and a recommendation: walk, renegotiate, or proceed.

What's read
CIM
What's missing
Cracks
What gets defended
Defensible diligence

Diligence isn't reading the CIM. It's reading the document the CIM was written to obscure.

If you're running diligence and want a second set of eyes on the cracks, I'd be glad to talk. More on product due diligence for private equity.